Fennec Pharmaceuticals Inc.

États‑Unis d’Amérique


 
Quantité totale PI 25
Rang # Quantité totale PI 59 011
Note d'activité PI 2,3/5.0    28
Rang # Activité PI 28 163
Symbole boursier
ISIN CA31447P1009
Capitalisation 171M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

12 4
2 0
3 0
4
 
Dernier brevet 2024 - Anhydrous sodium thiosulfate and...
Premier brevet 2018 - Method for reducing ototoxicity ...
Dernière marque 2023 - PEDMARQSI
Première marque 2017 - PEDMARK

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity fr...
Invention Therapeutic uses for sodium thiosulfate formulations. Described herein is anhydrous sodium thiosu...
2023 Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thio...
2022 P/S Patient administration services, namely, enrolling patients in the patient assistance programs of...
Invention Therapeutic uses for sodium thiosulfate and formulations. Described herein is anhydrous sodium th...
Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thios...
P/S Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportun...
2019 Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, ...
Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, m...
2018 Invention Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy. Desc...